University of Washington Gynecologic Oncology

Topics

• Ovarian cancer diagnosis and treatment 263
• Endometrial and Cervical Cancer Treatments 153
• Immunotherapy and Immune Responses 118
• PARP inhibition in cancer therapy 104
• Gestational Trophoblastic Disease Studies 98
• BRCA gene mutations in cancer 70
• Bariatric Surgery and Outcomes 61
• Appendicitis Diagnosis and Management 48
• Cancer Immunotherapy and Biomarkers 46
• Uterine Myomas and Treatments 40
• Cervical Cancer and HPV Research 35
• Global Cancer Incidence and Screening 30

Most cited

1. Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 486 citations · Renata Urban

2. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 914 citations · Barbara Norquist

3. NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 349 citations · Renata Urban

4. Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 323 citations · Kathryn Pennington

5. Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 587 citations · Heidi Gray

6. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 289 citations ·